Updated:
SemperVirens Ventures
SemperVirens Ventures, founded in 2018, deploys employer-partnered capital into workforce health, wealth, and productivity startups. Over $150M deployed.
SemperVirens Ventures
SemperVirens Ventures launched in 2018 when Rob Carroll, Colin Tobias, and Allison Baum Gates built a venture capital platform purpose-built for the workforce ecosystem. The firm's name — Latin for "always growing" — signals its thesis that technology serving employees, from health benefits to financial wellness, represents an under-allocated category relative to its economic weight. The founding team brought operating and investment experience from firms including Bain Capital Ventures and Trinity Ventures, but the structural insight was that the buyers in their target market — HR and benefits leaders at large employers — could double as a proprietary sourcing and diligence network if brought inside the fund structure. The firm invests at the pre-seed and seed stages, targeting companies at the intersection of work, health, and wealth. Its portfolio spans digital health platforms, workforce financial wellness tools, insurance technology, and AI applications that serve HR departments. Confirmed portfolio companies include Carrum Health, a surgery bundling platform that connects self-insured employers to high-quality care (per the firm, 2021), and Origin, a financial planning benefit for employees (per the firm, 2021). The firm also backed 1upHealth, an interoperability platform for health data, and Rain, an earned wage access provider. SemperVirens sources deals through its ecosystem council — a curated group of chief human resources officers, benefits consultants, and health plan executives who provide market intelligence that functions as a secondary sourcing engine. The firm invests across the United States, with a concentration of portfolio activity in the Bay Area and Boston health-tech corridors. The firm publicly reports that its ecosystem partners collectively represent more than 10 million covered lives and employees, giving the general partners a view into benefits procurement decisions that generalist seed funds cannot replicate. SemperVirens has raised multiple vehicles, including an initial fund and a subsequent opportunity fund for follow-on investments, though specific fund sizes remain undisclosed. In January 2024, the firm announced an additional partnership with leading employers to expand its healthcare cost reduction portfolio, signaling continued conviction in the employer-driven distribution thesis (per the firm, January 2024). Allison Baum Gates, a general partner, also leads the firm's work bridging the portfolio to the HR buyer community through events and content programming that doubles as relationship cultivation. The structural differentiator is the partnership model itself. Rather than relying solely on traditional LP capital, SemperVirens integrates its strategic limited partners — large self-insured employers, benefits brokers, and health plan administrators — as active participants in the investment process. These ecosystem members participate in deal evaluation, often pilot portfolio products with their own workforces, and serve as enterprise reference customers for portfolio companies seeking to scale. This architecture gives the firm demand-side feedback loops that most early-stage investors access only indirectly and only much later in company lifecycles. The governance model keeps the general partners as the sole decision-makers on investment committees, but the ecosystem council's structured input shapes the sourcing agenda and provides commercialization pathways that function as a durability mechanism for portfolio companies entering regulated, slow-moving enterprise markets.
General information
Firm type
Asset Manager
Year founded
2018
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Carlos
Corporate office
San Carlos, CA, United States
Principals
Rob Carroll
General Partner
Colin Tobias
General Partner
Allison Baum Gates
General Partner
Sector focus
Frequently asked questions
Who runs investment decisions at SemperVirens Ventures?
General partners Rob Carroll, Colin Tobias, and Allison Baum Gates make all investment decisions. The firm's ecosystem council of HR and benefits executives provides sourcing and diligence input, but does not have committee voting power. The partnership model keeps decision-making authority with the three GPs.
How does SemperVirens source its deal flow?
SemperVirens sources primarily through its employer ecosystem council, a curated group of CHROs, benefits leaders, and health plan administrators. These partners surface pain points from their own organizations and refer startups that have demonstrated traction with enterprise buyers. The firm supplements this with traditional venture networks, but the ecosystem council is the structural sourcing engine.
What stage does SemperVirens typically invest at?
The firm is concentrated at pre-seed and seed stages. SemperVirens writes first-check investments and maintains reserves for follow-on through a dedicated opportunity fund. The fund does not lead growth rounds but participates in early-stage extensions for top-performing portfolio companies.
Which sectors does the firm focus on, and are there any it explicitly avoids?
SemperVirens invests in workforce technology that spans digital health, financial wellness, insurtech, and AI applications for HR. The unifying theme is technology that serves employees through their employer relationship. The firm generally avoids consumer-direct health businesses without an employer distribution angle and stays away from direct-to-consumer models where the employer is not the primary channel.
How does SemperVirens create value beyond a capital investment?
The firm's ecosystem partners can pilot portfolio products with their own employee populations, providing real-world product feedback and an enterprise reference customer. The GPs also run programming that connects portfolio founders to benefits buyers at large self-insured employers. This distribution-access model is the firm's core argument for its relevance in competitive seed rounds.
Is SemperVirens structured as a family office or a traditional venture fund?
SemperVirens operates as a traditional venture capital firm structured around committed fund vehicles. It is not a family office. The firm raises capital from institutional limited partners and strategic employer-partners through closed-end fund structures typical of early-stage venture firms.
Has SemperVirens had any notable liquidity events?
The firm's public track record remains early-stage, consistent with a 2018 vintage. Specific realized exits have not been publicly disclosed. Many portfolio companies remain private, and the firm's returns are still maturing. Institutional allocators evaluating the firm typically weigh the employer-ecosystem distribution thesis alongside the yet-unproven fund-level track record.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: